| Description |
Enabling Point-of-Care Diagnostics
August 10-11, 2009
The range of utility of point-of-care testing is broad, and ranges from influenza, HIV, emerging pathogens, cardiology, stroke, even cancer applications. The demand for automated and integrated systems and the number of players in the field is growing exponentially. This meeting will showcase technology development with the clinical perspective on
where the tests are needed and how they are being used. Case studies to illustrate the impact on patient management and quality of care will show striking examples of the new paradigm in medicine. This meeting will answer what the dominant technologies will be for POC, and how to influence the ommercialization and adoption of tests.
Trends in Cancer Diagnostics
August 10-11, 2009
Tremendous progress is being made in cancer diagnostics, and the proliferation of novel tests is truly historic. Gene expression panels
from microarray data and next-generation sequencing are being used for the early detection and prognosis of cancer. Tumor aggressiveness and therapy selection are being determined by these technologies, and
the number of companies competing in this space is growing rapidly. Plan to attend to learn key factors in implementation and adoption, and gather intelligence about the types of assays from experts in the field.
Clinical Adoption of Next Generation Diagnostics
August 11-12, 2009
Clinical adoption of molecular diagnostic by the medical community is vital to the success of novel tests. The process by which new testing protocols become accepted and get incorporated will be explored. Experts from the medical and regulatory community will be speaking on a diverse range of issues. Find out what factors influence the adoption and acceptance of your diagnostic test, and how to navigate the changing regulatory requirements.
Molecular Diagnostics for Infectious Disease
August 11-12, 2009
Attend this conference to get an insight into how molecular technologies are advancing the development of clinically useful diagnostic tests for infectious diseases in humans, animals and plants both in developed and developing worlds. Hear from leading edge
companies who have successfully launched products in this area, from research lab oratories developing cutting edge science in support of this area, smaller companies launching novel tests, the FDAs guidelines on
developing products in this area and feedback from Clinical Directors at reference, specialty, service, or central laboratories who ultimately use
these tests.
NextGenerationDx.com
|
|
